Skip to main content
SpringerLink
Log in

Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery

  • Protocol
  • First Online:
Proteomics for Drug Discovery

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1647))

Abstract

The discovery of novel drug targets and biomarkers via mass spectrometry (MS)-based proteomic analysis of clinical specimens has proven to be challenging. The wide dynamic range of protein concentration in clinical specimens and the high background/noise originating from highly abundant proteins in tissue homogenates and serum/plasma encompass two major analytical obstacles. Immunoaffinity depletion of highly abundant blood-derived proteins from serum/plasma is a well-established approach adopted by numerous researchers; however, the utilization of this technique for immunodepletion of tissue homogenates obtained from fresh frozen clinical specimens is lacking. We first developed immunoaffinity depletion of highly abundant blood-derived proteins from tissue homogenates, using renal cell carcinoma as a model disease, and followed this study by applying it to different tissue types. Tissue homogenate immunoaffinity depletion of highly abundant proteins may be equally important as is the recognized need for depletion of serum/plasma, enabling more sensitive MS-based discovery of novel drug targets, and/or clinical biomarkers from complex clinical samples. Provided is a detailed protocol designed to guide the researcher through the preparation and immunoaffinity depletion of fresh frozen tissue homogenates for two-dimensional liquid chromatography, tandem mass spectrometry (2D-LC-MS/MS)-based molecular profiling of tissue specimens in the context of drug target and/or biomarker discovery.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Johann DJ Jr, Blonder J (2007) Biomarker discovery: tissues versus fluids versus both. Expert Rev Mol Diagn 7(5):473–475

    Article  CAS  PubMed  Google Scholar 

  2. Puangpila C, Mayadunne E, Rassi SE (2015) Liquid-phase-based separation systems for depletion, pre-fractionation and enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis–an update covering the period 2011–2014. Electrophoresis 36(1):238–252

    Article  CAS  PubMed  Google Scholar 

  3. Bjorhall K, Miliotis T, Davidson P (2005) Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5(1):307–317

    Article  PubMed  Google Scholar 

  4. Faca V, Pitteri SJ, Newcomb L et al (2007) Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res 6(9):3558–3565

    Article  CAS  PubMed  Google Scholar 

  5. Yadav AK, Bhardwaj G, Basak T et al (2011) A systematic analysis of eluted fraction of plasma post immunoaffinity depletion: implications in biomarker discovery. PLoS One 6(9):e24442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Huang Z, Yan G, Gao M et al (2016) Array-based online two dimensional liquid chromatography system applied to effective depletion of high-abundance proteins in human plasma. Anal Chem 88(4):2440–2445

    Article  CAS  PubMed  Google Scholar 

  7. Borg J, Campos A, Diema C et al (2011) Spectral counting assessment of protein dynamic range in cerebrospinal fluid following depletion with plasma-designed immunoaffinity columns. Clin Proteomics 8:6–14

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Cheon DH, Nam EJ, Park KH et al (2016) Comprehensive analysis of low-molecular-weight human plasma proteome using top-down mass spectrometry. J Proteome Res 5(1):229–244

    Article  Google Scholar 

  9. Fountoulakis M, Juranville JF, Jiang L et al (2004) Depletion of the high-abundance plasma proteins. Amino Acids 27(3–4):249–259

    Article  CAS  PubMed  Google Scholar 

  10. Martosella J, Zolotarjova N, Liu H et al (2005) Reversed-phase high-performance liquid chromatographic pre-fractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins. J Proteome Res 4(5):1522–1537

    Article  CAS  PubMed  Google Scholar 

  11. Hyung SW, Piehowski PD, Moore RJ et al (2014) Microscale depletion of high abundance proteins in human biofluids using IgY14 immunoaffinity resin: analysis of human plasma and cerebrospinal fluid. Anal Bioanal Chem 406:7117–7125

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Galindo AN, Kussman M, Dayon L (2015) Proteomics of cerebrospinal fluid: throughput and robustness using a scalable automated analysis pipeline for biomarker discovery. Anal Chem 87(21):10755–10761

    Article  Google Scholar 

  13. Cellar NA, Karnoup AS, Albers DR (2009) Immunodepletion of high abundance proteins coupled on-line with reversed-phase liquid chromatography: a two-dimensional LC sample enrichment and fractionation technique for mammalian proteomics. J Chromatogr B Analyt Technol Biomed Life Sci 877(1–2):79–85

    Article  CAS  PubMed  Google Scholar 

  14. Bellei E, Bergamini S, Monari E et al (2011) High-abundance protein depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. Amino Acids 40:145–156

    Article  CAS  PubMed  Google Scholar 

  15. Millioni R, Tolin S, Puricelli L et al (2011) High abundance proteins depletion vs low abundance proteins enrichment: comparison of methods to reduce the plasma proteome complexity. PLoS One 6(5):e19603

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Janecki DJ, Pomerantz SC, Beil EJ et al (2012) A fully integrated multi-column system for abundant protein depletion from serum/plasma. J Chromatogr B Analyt Technol Biomed Life Sci 902:35–41

    Article  CAS  PubMed  Google Scholar 

  17. Kullolli M, Warren J, Arampatzidou M et al (2013) Performance evaluation of affinity ligands for depletion of abundant plasma proteins. J Chromatogr B Analyt Technol Biomed Life Sci 939:10–16

    Article  CAS  PubMed  Google Scholar 

  18. Johann DJ, Wei BR, Prieto DA et al (2010) Combined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinoma. Anal Chem 82(5):1584–1588

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Prieto DA, Johann DJ Jr, Wei BR et al (2014) Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens. Biomark Med 8(2):269–286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Blonder J, Chan KC, Issaq HJ et al (2006) Identification of membrane proteins from mammalian cell/tissue using methanol-facilitated solubilization and tryptic digestion coupled with 2D-LC-MS/MS. Nat Protoc 1(6):2784–2790

    Article  CAS  PubMed  Google Scholar 

  21. Tran JC, Doucette A (2008) Gel-eluted liquid fraction entrapment electrophoresis: an electrophoretic method for broad molecular weight range proteome separation. Anal Chem 80:1568–1573

    Article  CAS  PubMed  Google Scholar 

  22. Slebos RJ, Brock JW, Winters NF et al (2008) Evaluation of strong cation exchange versus isoelectric focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 12:5286–5294

    Article  Google Scholar 

  23. Dzieciatkowska M, Hill R, Hansen KC (2014) GeLC-MS/MS analysis of complex protein mixtures. Methods Mol Biol 1156:53–66

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Gundry RL, White MY, Murray CI et al (2010) Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow. Curr Protoc Mol Biol Chapter 10: Unit 10.25

    Google Scholar 

  25. Shevchenko A, Tomas H, Havlis J et al (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1(6):2856–2860

    Article  CAS  PubMed  Google Scholar 

  26. Giansanti P, Tsiatsiani L, Low TY et al (2016) Six alternative proteases for mass spectrometry-based proteomics beyond trypsin. Nat Protoc 11(5):993–1006

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

“This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.”

Author information

Authors and Affiliations

  1. Cancer Research Technology Program, Protein Characterization Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, PO Box B, Frederick, MD, 21702, USA

    DaRue A. Prieto & King C. Chan

  2. Wintrop P Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA

    Donald J. Johann Jr

  3. Cancer Research Technology Program, Antibody Characterization Laboratory, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, PO Box B, Frederick, MD, 21702, USA

    Xiaoying Ye, Gordon Whitely & Josip Blonder

Authors
  1. DaRue A. Prieto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. King C. Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Donald J. Johann Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiaoying Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gordon Whitely
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Josip Blonder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josip Blonder .

Editor information

Editors and Affiliations

  1. Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, USA

    Iulia M. Lazar

  2. Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, Illinois, USA

    Maria Kontoyianni

  3. ImmunoGen, Waltham, Massachusetts, USA

    Alexandru C. Lazar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Prieto, D.A., Chan, K.C., Johann, D.J., Ye, X., Whitely, G., Blonder, J. (2017). Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery. In: Lazar, I., Kontoyianni, M., Lazar, A. (eds) Proteomics for Drug Discovery. Methods in Molecular Biology, vol 1647. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7201-2_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7201-2_5

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7200-5

  • Online ISBN: 978-1-4939-7201-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation